TradeFlare's AI research teams analysed CGON on 7 market nights between April 29, 2026 and September 4, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 4, 2026 | HOLD | $74.33 | — / — | -1.2% | -8.0% | The current market regime and stock-specific factors do not support a BUY recommendation at this time. |
| August 31, 2026 | BUY | $74.34 | $80.46 / $60.93 | -2.3% | -6.2% | The setup suggests a short-term bounce play with potential for a longer-term uptrend if fundamental catalysts materialize. |
| June 30, 2026 | BUY | $73.73 | $90.00 / $62.67 | -1.8% | -2.7% | The setup suggests a near-term breakout potential driven by technical momentum and fundamental catalysts. |
| June 25, 2026 | BUY | $68.72 | — / — | -3.4% | -4.8% | The scanner trigger suggests a short-term post-earnings drift, but the technicals are bearish and risk is high. |
| May 4, 2026 | BUY | $66.27 | — / — | +2.4% | -18.0% | Positive clinical trial data for cretostimogene. |
| April 30, 2026 | BUY | $64.75 | — / — | +3.7% | -6.7% | Positive clinical trial data for cretostimogene. |
| April 29, 2026 | BUY | $65.55 | $75.00 / $55.94 | +5.0% | -6.2% | The bullish fundamental and sentiment indicators suggest a potential upward trend, but the neutral technicals and high risk necessitate a patient approach. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.